Evidence map›Paper›PMID 30420556›Full record

ArticleThe EMBO journal2018

Excessive tubulin polyglutamylation causes neurodegeneration and perturbs neuronal transport.

Maria M Magiera, Satish Bodakuntla, Jakub Žiak, Sabrina Lacomme, Patricia Marques Sousa, Sophie Leboucher, Torben J Hausrat, Christophe Bosc, Annie Andrieux, Matthias Kneussel and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 151 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Imaging microtubule dynamics: A new frontier in biomarker development for neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Maria M MagieraInstitut Curie, CNRS UMR3348, PSL Research University, Orsay, France maria.magiera@curie.fr carsten.janke@curie.fr.ORCID 0000-0003-4847-3053
Satish BodakuntlaInstitut Curie, CNRS UMR3348, PSL Research University, Orsay, France.ORCID 0000-0002-0448-7683
Jakub ŽiakDepartment of Molecular Neurobiology, Institute of Physiology, Czech Academy of Sciences, Prague 4, Czech Republic.
Sabrina LacommeBordeaux Imaging Center, BIC, UMS 3420, Université Bordeaux, Bordeaux, France.
Patricia Marques SousaInstitut Curie, CNRS UMR3348, PSL Research University, Orsay, France.
Sophie LeboucherInstitut Curie, CNRS UMR3348, PSL Research University, Orsay, France.
Torben J HausratCenter for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christophe BoscGrenoble Institut des Neurosciences, GIN, Université Grenoble Alpes, Grenoble, France.
Annie AndrieuxGrenoble Institut des Neurosciences, GIN, Université Grenoble Alpes, Grenoble, France.
Matthias KneusselCenter for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Marc LandryInterdisciplinary Institute for Neuroscience, CNRS UMR5297, Université Bordeaux, Bordeaux, France.
André CalasInterdisciplinary Institute for Neuroscience, CNRS UMR5297, Université Bordeaux, Bordeaux, France.
Martin BalastikDepartment of Molecular Neurobiology, Institute of Physiology, Czech Academy of Sciences, Prague 4, Czech Republic.
Carsten JankeInstitut Curie, CNRS UMR3348, PSL Research University, Orsay, France maria.magiera@curie.fr carsten.janke@curie.fr.ORCID 0000-0001-7053-2000
Université Paris-Sud · FRCentre National de la Recherche Scientifique · FRCzech Academy of Sciences · CZInserm · FRUniversität Hamburg · DEUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posttranslational modifications of tubulin are emerging regulators of microtubule functions. We have shown earlier that upregulated polyglutamylation is linked to rapid degeneration of Purkinje cells in mice with a mutation in the deglutamylating enzyme CCP1. How polyglutamylation leads to degeneration, whether it affects multiple neuron types, or which physiological processes it regulates in healthy neurons has remained unknown. Here, we demonstrate that excessive polyglutamylation induces neurodegeneration in a cell-autonomous manner and can occur in many parts of the central nervous system. Degeneration of selected neurons in CCP1-deficient mice can be fully rescued by simultaneous knockout of the counteracting polyglutamylase TTLL1. Excessive polyglutamylation reduces the efficiency of neuronal transport in cultured hippocampal neurons, suggesting that impaired cargo transport plays an important role in the observed degenerative phenotypes. We thus establish polyglutamylation as a cell-autonomous mechanism for neurodegeneration that might be therapeutically accessible through manipulation of the enzymes that control this posttranslational modification.

Indexed as

Protein Processing, Post-TranslationalAnimalsBiological Transport, ActiveMiceMice, KnockoutNerve Tissue ProteinsNeurodegenerative DiseasesPeptidesPeptide SynthasesPurkinje CellsTubulinCcdc115 protein, mouseNerve Tissue ProteinsPeptidesPeptide SynthasespolyglutamineTubulintubulin polyglutamylaseaxonal transportneurodegenerationtubulin codetubulin polyglutamylationtubulin posttranslational modifications

Identifiers

PMID30420556
PMCPMC6276888
OpenAlexW2900516743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.